No man wants to hear “You’ve got prostate cancer”. Al Piazza had just retired from his job in California and was devastated to hear that he had been diagnosed with prostate cancer. He felt that his whole future ahead of him was over, as a result of his diagnosis. Thankfully, Al’s doctor, Dr. Jeremy Lieb introduced him to the Prolaris test. Upon hearing about Prolaris, Al was eager to find out what the progression of his cancer was expected to look like. Fortunately, for Al, the results from his Prolaris test showed that he only had a three percent chance of his cancer progressing over the next ten years. With the help of Prolaris, Al was able to worry less about his cancer and enjoy life again.
Dr Lieb explains that the Prolaris test is a genetic test for prostate cancer. What this means is that it looks into the actual DNA of the cells. In doing this, it is easier to determine how fast each individual cancer cell is going to grow in the future. Which can then help physicians and patients better diagnose a proper treatment plan that is unique to their particular prostate cancer.
Join Dr. Jeremy Lieb, a physician and board-certified Urologist from California, and Al Piazza, who lives with prostate cancer, for a real-world view of what the latest genetic testing for prostate cancer means for those faced with a prostate cancer diagnosis.
Al’s story aired on WTLV-First Coast News, Jacksonville.